About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Enalapril Maleate

Company: Baylor Research Institute
Mechanism: Mechanism not yet reported
Route: Route not yet reported
Recruiting trials: 13 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

13 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Trial details

Recruiting NCT NCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites

Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
View official trial listing →
Recruiting NCT NCT02817360

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites

Type 2 diabetes Other conditions: Heart Diseases
View official trial listing →
Recruiting NCT NCT03460366

Bariatric Surgery and Pharmacokinetics of Enalapril

Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 site

Other conditions: Obesity, Morbid
View official trial listing →
Recruiting NCT NCT04183101

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Not yet reported Region Skane 30 participants Est. completion 2029-12 4 sites Stand-alone

Other conditions: C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality, Dense Deposit Disease, C3 Glomerulonephritis
View official trial listing →
Recruiting NCT NCT04191681

Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study

Not yet reported The Cleveland Clinic 50 participants Est. completion 2022-12 1 site

Heart failure
View official trial listing →
Recruiting NCT NCT05498675

Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site

Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
View official trial listing →
Recruiting NCT NCT05593055

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

Not yet reported Brigham and Women's Hospital 75 participants Est. completion 2027-12-31 1 site

Other conditions: Hypertension, Left Ventricular Hypertrophy
View official trial listing →
Recruiting NCT NCT06218199

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

Not yet reported Heart Center Research, LLC 80 participants Est. completion 2026-12-31 1 site

Heart failure
View official trial listing →
Recruiting NCT NCT06788314

A Study of Enalapril in Treatment of Venous Malformations

Not yet reported Oslo University Hospital 12 participants Est. completion 2030-12-01 1 site Stand-alone

Other conditions: Venous Malformation, Pain, Quality of Life, Vascular Malformation
View official trial listing →
Recruiting NCT NCT07023003

Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

Not yet reported Nebraska Methodist Health System 850 participants Est. completion 2028-12 1 site Stand-alone

Other conditions: Hypertension in Pregnancy
View official trial listing →
Recruiting NCT NCT07222852

Cardiovascular Protection After Preeclampsia With Enalapril

Not yet reported Women and Infants Hospital of Rhode Island 60 participants Est. completion 2027-10-15 1 site Stand-alone

Other conditions: Preeclampsia, Hypertensive Disorder of Pregnancy, Hypertension, Gestational Hypertension, Gestational Hypertension After Childbirth
View official trial listing →
Recruiting NCT NCT07363343

Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study

Not yet reported The Cleveland Clinic 200 participants Est. completion 2029-12-31 1 site Stand-alone

Other conditions: Hypertension, Postpartum Preeclampsia
View official trial listing →
Recruiting NCT NCT07513883

The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT00000516

Studies of Left Ventricular Dysfunction (SOLVD)

Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1990-05

Cardiovascular diseaseHeart failure Other conditions: Coronary Disease, Heart Diseases, Hypertension, Myocardial Ischemia
View official trial listing →
Completed NCT NCT00000522

Treatment of Mild Hypertension Study (TOMHS)

Not yet reported University of Minnesota Est. completion 1994-05

Cardiovascular disease Other conditions: Heart Diseases, Hypertension, Vascular Diseases
View official trial listing →
Completed NCT NCT00000547

Enalapril After Anthracycline Cardiotoxicity

Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2001-02

Cardiovascular diseaseHeart failure Other conditions: Heart Diseases, Myocardial Diseases
View official trial listing →
Completed NCT NCT00001534

Long Term Effects of Enalapril and Losartan on Genetic Heart Disease

National Heart, Lung, and Blood Institute (NHLBI) 112 participants Est. completion 2003-04 1 site

Other conditions: Hypertrophic Cardiomyopathy, Left Ventricular Hypertrophy, Myocardial Ischemia
View official trial listing →
Completed NCT NCT00003070

Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer

Not yet reported Children's Oncology Group 13 participants Est. completion 2007-03 61 sites Stand-alone

Other conditions: Cardiac Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
View official trial listing →
Completed NCT NCT00004328

Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I

Not yet reported National Center for Research Resources (NCRR) 1 participants

Other conditions: Pseudohypoaldosteronism
View official trial listing →
Completed NCT NCT00006137

Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy

Not yet reported National Center for Research Resources (NCRR) 43 participants

Other conditions: IGA Glomerulonephritis
View official trial listing →
Completed NCT NCT00113087

Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network

Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 230 participants Est. completion 2008-07 9 sites

Heart failure Other conditions: Heart Defects, Congenital
View official trial listing →
Terminated NCT NCT00113698

Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation

Not yet reported University of Utah 5 participants Est. completion 2006-01 7 sites

Heart failure Other conditions: Heart Defects, Congenital, Heart Septal Defects, Ventricular
View official trial listing →
Terminated NCT NCT00141583

The Renin-Angiotensin System in Essential Hypertension

Not yet reported St George's, University of London 11 participants Est. completion 2006-10 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00143949

Renin Angiotensin System Study (RASS/B-RASS)

Not yet reported Michael Mauer, MD 285 participants Est. completion 2008-05 3 sites

Other conditions: Type 1 Diabetes
View official trial listing →
Terminated NCT NCT00151619

Effects of Amlodipine in the Management of Chronic Heart Failure

Not yet reported Rennes University Hospital 7 participants 2 sites

Heart failure
View official trial listing →
Completed NCT NCT00160160

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes

Not yet reported Solvay Pharmaceuticals 440 participants 63 sites

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00226096

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Not yet reported The George Institute 404 participants Est. completion 2007-09 20 sites

Other conditions: CVA (Cerebrovascular Accident), Cerebral Hemorrhage, Intracranial Hemorrhages
View official trial listing →
Status unknown NCT NCT00235287

Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease

Not yet reported Herlev Hospital 60 participants 1 site

Cardiovascular disease Other conditions: Kidney Failure, Chronic
View official trial listing →
Completed NCT NCT00248807

A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.

Not yet reported VA Office of Research and Development 30 participants Est. completion 2012-04 1 site

Other conditions: Orthostatic Hypotension, Spinal Cord Injuries
View official trial listing →
Completed NCT NCT00270153

The Use of ACE Inhibitors in the Early Renal Post-transplant Period

Not yet reported Montefiore Medical Center 110 participants Est. completion 2009-12 1 site

Other conditions: Renal Transplant
View official trial listing →
Completed NCT NCT00274118

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Not yet reported Boehringer Ingelheim 250 participants Est. completion 2004-01 37 sites

Type 2 diabetes Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00292162

Curing Atrial Fibrillation in Heart Failure

Not yet reported NHS Greater Glasgow and Clyde 41 participants Est. completion 2009-07 1 site

Heart failure Other conditions: Atrial Fibrillation
View official trial listing →
Completed NCT NCT00292526

Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients

Not yet reported European Institute of Oncology 114 participants Est. completion 2011-11 1 site Stand-alone

Other conditions: Cardiotoxicity, Chemotherapeutic Toxicity
View official trial listing →
Completed NCT NCT00295542

Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00296218

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Not yet reported Sanofi 440 participants 11 sites

Other conditions: Myocardial Ischemia, Hypertension
View official trial listing →
Completed NCT NCT00302705

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Not yet reported University of Vigo 150 participants Est. completion 2007-03 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00354328

Heart Function and Exercise Capacity in Patients With Hypertrophic Cardiomyopathy

National Heart, Lung, and Blood Institute (NHLBI) 110 participants Est. completion 2013-10-22 1 site

Cardiovascular disease Other conditions: Angina, Unstable, Ischemic Heart Disease
View official trial listing →
Completed NCT NCT00367562

Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

Not yet reported Hospital Britanico 20 participants Est. completion 2005-12 1 site

Other conditions: IGA Nephropathy
View official trial listing →
Completed NCT NCT00367978

Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus

Not yet reported Novartis 275 participants Est. completion 2003-09 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00391846

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Not yet reported AstraZeneca 252 participants Est. completion 2009-01 39 sites

Heart failure Other conditions: Ventricular Dysfunction, Left
View official trial listing →
Completed NCT NCT00394394

Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril

Not yet reported Hospital de Clinicas de Porto Alegre 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00396721

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Not yet reported Josep m Cruzado 23 participants Est. completion 2010-02 1 site Stand-alone

Other conditions: Glomerulonephritis, IGA, Nephropathy, IGA, IGA Nephropathy
View official trial listing →
Completed NCT NCT00419835

Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

Not yet reported University of Sao Paulo 80 participants Est. completion 2007-09 1 site

Chronic kidney disease
View official trial listing →
Status unknown NCT NCT00427271

Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Not yet reported Hospital de Clinicas de Porto Alegre 20 participants Est. completion 2007-01 1 site

Other conditions: Diabetes Mellitus, Microalbuminuria
View official trial listing →
Completed NCT NCT00433836

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure

Not yet reported Novartis Pharmaceuticals 300 participants Est. completion 2009-02 11 sites

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00446511

Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

Not yet reported Novartis Pharmaceuticals 250 participants Est. completion 2009-06 9 sites Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00446862

The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

University of Alabama at Birmingham 36 participants Est. completion 2012-12 6 sites

Other conditions: Fabry Disease, Proteinuria
View official trial listing →
Terminated NCT NCT00456963

Prevention of Diabetes and Hypertension

Not yet reported Istituto Auxologico Italiano 3000 participants Est. completion 2010-03 1 site Stand-alone

Other conditions: Diabetes Mellitus, Hypertension
View official trial listing →
Completed NCT NCT00484068

Chicken-Diet vs. Enalapril to Reduce Albuminuria

Not yet reported Hospital de Clinicas de Porto Alegre 28 participants Est. completion 2006-06 1 site

Chronic kidney disease Other conditions: Microalbuminuria
View official trial listing →
Completed NCT NCT00520247

Effect of Enalapril Plus Folic Acid on Blood Pressure and Glycometabolism

Not yet reported Anhui Medical University 443 participants Est. completion 2006-02 1 site

Other conditions: Plasma Total Homocysteine Level, Blood Pressure
View official trial listing →
Completed NCT NCT00543413

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

Not yet reported Merck Sharp & Dohme LLC 160 participants Est. completion 2008-06

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00568178

An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

Not yet reported Organon and Co 306 participants Est. completion 2011-03-01 Stand-alone

Other conditions: Proteinuria
View official trial listing →
Completed NCT NCT00603590

Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease

Not yet reported Tehran University of Medical Sciences 475 participants Est. completion 2008-07 1 site Stand-alone

Cardiovascular disease Other conditions: Hypertension, Hyperlipidemia, Heart Disease
View official trial listing →
Completed NCT NCT00666848

Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome

Not yet reported Vanderbilt University 24 participants Est. completion 2010-01 1 site

Metabolic syndrome Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00684489

Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00716079

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

Not yet reported The George Institute 2839 participants Est. completion 2012-12 62 sites

Cardiovascular disease Other conditions: Intracerebral Hemorrhage, Hypertension
View official trial listing →
Status unknown NCT NCT00734123

Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

Not yet reported Hospital Arnau de Vilanova 2948 participants Est. completion 2013-05 1 site Stand-alone

Cardiovascular disease Other conditions: Atherosclerosis
View official trial listing →
Completed NCT NCT00741156

The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution

Not yet reported The Hospital for Sick Children 12 participants Est. completion 2010-01 1 site

Other conditions: Hypertension, Congestive Cardiomyopathy
View official trial listing →
Completed NCT NCT00741585

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites

Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
View official trial listing →
Completed NCT NCT00794885

China Stroke Primary Prevention Trial

Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 20702 participants Est. completion 2014-06 2 sites Stand-alone

Other conditions: Primary Hypertension
View official trial listing →
Completed NCT NCT00853658

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Not yet reported Novartis Pharmaceuticals 7064 participants Est. completion 2015-10 806 sites Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT00882440

A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)

Not yet reported Merck Sharp & Dohme LLC 576 participants Est. completion 1992-01

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT00895414

Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer

Not yet reported Masonic Cancer Center, University of Minnesota 19 participants Est. completion 2015-10 2 sites Stand-alone

Other conditions: Breast Cancer
View official trial listing →
Status unknown NCT NCT00899587

Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia

Not yet reported Shahid Beheshti University of Medical Sciences 1 site Stand-alone

Other conditions: Diabetic Macular Ischemia
View official trial listing →
Completed NCT NCT00963976

Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial

Not yet reported University of Alberta 74 participants Est. completion 2012-02 4 sites Stand-alone

Other conditions: Intracerebral Hemorrhage
View official trial listing →
Completed NCT NCT01007994

Reduction of Night-time Blood Pressure in Pediatric Renal Transplant Recipients

Not yet reported, Not yet reported Northwell Health 33 participants Est. completion 2020-08 2 sites

Other conditions: Hypertension Secondary to Kidney Transplant
View official trial listing →
Completed NCT NCT01015937

Effect of Turmeric on Diabetic Nephropathy

Not yet reported Shaheed Faghihi Hospital 50 participants Est. completion 2009-08 1 site

Chronic kidney disease Other conditions: Proteinuria
View official trial listing →
Terminated NCT NCT01035255

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

Not yet reported Novartis Pharmaceuticals 8442 participants Est. completion 2014-05 1031 sites Stand-alone

Heart failure
View official trial listing →
Status unknown NCT NCT01041963

The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

Not yet reported Chulalongkorn University 90 participants Est. completion 2010-09 1 site

Other conditions: Continuous Ambulatory Peritoneal Dialysis
View official trial listing →
Completed NCT NCT01061450

Simvastatin and Diastolic Dysfunction

Not yet reported Brasilia Heart Study Group 55 participants Est. completion 2009-08 1 site

Other conditions: Diastolic Dysfunction, Hypertension
View official trial listing →
Status unknown NCT NCT01069042

Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human

Not yet reported National Cheng-Kung University Hospital 60 participants Est. completion 2010-11 1 site Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT01074281

An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH)

Merck KGaA, Darmstadt, Germany 2065 participants Est. completion 2009-08

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01093807

Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension

Not yet reported RECORDATI GROUP 1039 participants Est. completion 2011-04 1 site Stand-alone

Other conditions: Essential Hypertension
View official trial listing →
Terminated NCT NCT01096121

Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children

Not yet reported Assistance Publique - Hôpitaux de Paris 5 participants Est. completion 2012-06 1 site Stand-alone

Other conditions: Sickle Cell Disease
View official trial listing →
Completed NCT NCT01110824

Prevention of Left Ventricular Dysfunction During Chemotherapy

Not yet reported Hospital Clinic of Barcelona 90 participants Est. completion 2012-03 2 sites Stand-alone

Other conditions: Acute Myeloid Leukemia, Precursor-cell Lymphoblastic Leukemia-Lymphoma, Lymphoid Neoplasm, Multiple Myeloma, Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
View official trial listing →
Completed NCT NCT01115946

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Enalapril in Healthy Volunteers

Not yet reported Astellas Pharma Inc 24 participants Est. completion 2010-04 1 site Stand-alone

Other conditions: Healthy, Pharmacokinetics of Enalapril
View official trial listing →
Completed NCT NCT01117038

Drug Interaction Study of Avanafil and Enalapril or Amlodipine

Not yet reported VIVUS LLC 48 participants Est. completion 2010-05 1 site Stand-alone

Other conditions: Erectile Dysfunction
View official trial listing →
Completed NCT NCT01151410

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Not yet reported Novartis Pharmaceuticals 208 participants Est. completion 2015-08 36 sites

Other conditions: Hypertension
View official trial listing →
Terminated NCT NCT01211314

Antihypertensive Efficacy of Fixed Combination Drug

Not yet reported Meir Medical Center 10 participants Est. completion 2012-04 1 site Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01271985

Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

Not yet reported Tehran University of Medical Sciences 8410 participants Est. completion 2019-01 1 site

Cardiovascular disease
View official trial listing →
Status unknown NCT NCT01305850

The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients

Not yet reported Chulalongkorn University 100 participants Est. completion 2011-10 1 site

Other conditions: Peritoneal Membrane Failure
View official trial listing →
Completed NCT NCT01318564

Diabetic Treatment Adherence

M.D. Anderson Cancer Center 28 participants Est. completion 2016-08 2 sites

Other conditions: Endocrine System Diseases
View official trial listing →
Completed NCT NCT01324245

Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet

Not yet reported Georgetown University 45 participants Est. completion 2006-05 1 site Stand-alone

Other conditions: Salt-sensitive Hypertension
View official trial listing →
Status unknown NCT NCT01364675

Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects

Not yet reported Ramathibodi Hospital 8900 participants Est. completion 2016-12 1 site Stand-alone

Prediabetes Other conditions: Pre-hypertension
View official trial listing →
Completed NCT NCT01411735

Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure

Not yet reported Wake Forest University 71 participants Est. completion 2008-07

Heart failure
View official trial listing →
Completed NCT NCT01413542

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

Not yet reported Vanderbilt University 44 participants Est. completion 2014-07 1 site

Other conditions: Hypertension, Diabetes Type 2
View official trial listing →
Completed NCT NCT01422616

Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)

Not yet reported The George Institute 4587 participants Est. completion 2018-08 1 site

Cardiovascular disease Other conditions: High Blood Pressure
View official trial listing →
Completed NCT NCT01437371

Is There a Benefit to Optimize Heart Failure (HF) Treatment in Aged Over 80 Year's Old Patients?

Not yet reported University Hospital, Clermont-Ferrand 35 participants Est. completion 2014-06 1 site

Heart failure
View official trial listing →
Completed NCT NCT01465126

Enalapril in Collagen Type 4 Nephropathy

University of Sao Paulo 19 participants Est. completion 2011-10

Other conditions: Collagen Type-4 Nephropathies
View official trial listing →
Completed NCT NCT01557140

A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy

Not yet reported Federal University of Minas Gerais 42 participants Est. completion 2006-12 1 site Stand-alone

Heart failure Other conditions: Chagas Cardiomyopathy, Dilated Cardiomyopathy
View official trial listing →
Status unknown NCT NCT01624064

Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

Not yet reported, Not yet reported Ministry of Health, Sri Lanka 200 participants Est. completion 2013-10 1 site

Other conditions: Renal Insufficiency, Chronic
View official trial listing →
Withdrawn NCT NCT01631409

Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy

City Hospital No 40, Saint Petersburg, Russia Est. completion 2021-09

Other conditions: Coronary Heart Disease (CHD)
View official trial listing →
Completed NCT NCT01667614

Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Not yet reported Tehran University of Medical Sciences 136 participants Est. completion 2012-07 1 site

Type 2 diabetesChronic kidney disease Other conditions: Essential Hypertension
View official trial listing →
Completed NCT NCT01669434

Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site

Other conditions: Hypotension on Induction
View official trial listing →
Terminated NCT NCT01705392

Bevacizumab vs Dacarbazine in Metastatic Melanoma

Not yet reported Haukeland University Hospital 2 participants Est. completion 2017-02-20 1 site Stand-alone

Other conditions: Metastatic Malignant Melanoma, Unresectable Malignant Melanoma
View official trial listing →
Status unknown NCT NCT01715584

Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT01754909

Mitigation of Radiation Pneumonitis and Fibrosis

Not yet reported VA Office of Research and Development 50 participants Est. completion 2018-04-01 3 sites

Other conditions: Lung Cancer, Radiation Pneumonitis
View official trial listing →
Completed NCT NCT01822639

A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

Not yet reported GlaxoSmithKline 15 participants Est. completion 2013-05-24 1 site Stand-alone

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT01832558

The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)

Not yet reported Medical University of Vienna 24 participants Est. completion 2021-12-31 1 site Stand-alone

Chronic kidney disease
View official trial listing →
Completed NCT NCT01839253

The Effect of Antihypertensive Agents Concerning With Hemodynamics and Reduction of Anaesthetics in Orthognathic Surgery

Not yet reported Yonsei University 75 participants Est. completion 2014-03 1 site Stand-alone

Other conditions: Orthognathic Surgery
View official trial listing →
Completed NCT NCT01840072

China Antihypertensive Trial in Acute Ischemic Stroke

Not yet reported Tulane University 4071 participants Est. completion 2016-05 1 site Stand-alone

Cardiovascular disease
View official trial listing →
Terminated NCT NCT01867047

ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone

Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
View official trial listing →
Withdrawn NCT NCT01871740

CSPPT- Chronic Kidney Diseases Study

Not yet reported Shenzhen Ausa Pharmed Co.,Ltd Est. completion 2014-08 2 sites Stand-alone

Other conditions: Hypertension, Hyperhomocysteinemia
View official trial listing →
Status unknown NCT NCT01891292

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

Not yet reported The University of The West Indies 30 participants Est. completion 2015-09 1 site

Other conditions: Microalbuminuria, Sickle Cell Nephropathy
View official trial listing →
Status unknown NCT NCT01968200

Prevention of Anthracycline-induced Cardiotoxicity

Not yet reported European Institute of Oncology 268 participants Est. completion 2023-12 1 site Stand-alone

Other conditions: Cancer
View official trial listing →
Terminated NCT NCT02088450

Systolic Hypertension in Europe Placebo-Controlled Trial

Not yet reported KU Leuven 4695 participants Est. completion 1997-02

Other conditions: Isolated Systolic Hypertension
View official trial listing →
Completed NCT NCT02135263

Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype

Not yet reported Bispebjerg Hospital 44 participants Est. completion 2014-05 1 site Stand-alone

Other conditions: Carboxylesterase 1 (CES1) Genotype, CES1 Activity
View official trial listing →
Completed NCT NCT02177448

BIBR 277 Capsule in Patients With Essential Hypertension

Not yet reported Boehringer Ingelheim 225 participants Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT02177461

Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension

Not yet reported Boehringer Ingelheim 374 participants

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT02200822

Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

Not yet reported Hasselt University 80 participants Est. completion 2019-02 1 site

Heart failure
View official trial listing →
Status unknown NCT NCT02214498

Treatment of HYpertension: Morning Versus Evening

Not yet reported Erasmus Medical Center 120 participants Est. completion 2017-05 1 site

Other conditions: Essential Hypertension
View official trial listing →
Status unknown NCT NCT02252692

Relative Bioavailability Study With Enalapril in Healthy Volunteers

Not yet reported Ethicare GmbH 24 participants Est. completion 2014-10 1 site Stand-alone

Heart failure
View official trial listing →
Terminated NCT NCT02281838

The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II

Not yet reported University of Alberta 142 participants Est. completion 2021-12 2 sites Stand-alone

Other conditions: Intracerebral Hemorrhage
View official trial listing →
Completed NCT NCT02432885

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial

Not yet reported InCor Heart Institute 76 participants Est. completion 2013-06 Stand-alone

Other conditions: Myocardial Fibrosis, Muscular Dystrophies
View official trial listing →
Completed NCT NCT02468232

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

Not yet reported Novartis Pharmaceuticals 225 participants Est. completion 2021-02-18 49 sites Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT02554890

Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.

Not yet reported Novartis Pharmaceuticals 887 participants Est. completion 2018-07-24 123 sites Stand-alone

Heart failure
View official trial listing →
Status unknown NCT NCT02571842

Rituximab in Recurrent IgA Nephropathy

Not yet reported Chulalongkorn University 30 participants Est. completion 2016-12 1 site

Other conditions: Recurrent IgA Nephropathy
View official trial listing →
Completed NCT NCT02575092

The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment

Not yet reported, Not yet reported Fuling Central Hospital of Chongqing City 4000 participants Est. completion 2019-07-31 1 site Stand-alone

Other conditions: Homocysteine, Coronary Disease, Angioplasty,Balloon,Coronary, Contrast Media, Nephropathy, Hypertension
View official trial listing →
Status unknown NCT NCT02623036

The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

Not yet reported Memorial Health University Medical Center 20 participants Est. completion 2018-04 1 site

Other conditions: Hypertension, Resistant to Conventional Therapy
View official trial listing →
Completed NCT NCT02639637

Effect of DPP4 Inhibition on Vasoconstriction

Not yet reported Vanderbilt University 18 participants Est. completion 2017-09 1 site

Type 2 diabetes
View official trial listing →
Status unknown NCT NCT02652728

Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy

Not yet reported, Not yet reported Ethicare GmbH 50 participants Est. completion 2017-06 6 sites Stand-alone

Heart failure Other conditions: Dilated Cardiomyopathy
View official trial listing →
Status unknown NCT NCT02652741

Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease

Not yet reported, Not yet reported Ethicare GmbH 50 participants Est. completion 2017-06 6 sites Stand-alone

Heart failure Other conditions: Congenital Heart Disease
View official trial listing →
Status unknown NCT NCT02654678

Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril

Not yet reported, Not yet reported Ethicare GmbH 100 participants Est. completion 2018-04 6 sites Stand-alone

Heart failure Other conditions: Dilated Cardiomyopathy, Congenital Heart Disease
View official trial listing →
Completed NCT NCT02678312

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure

Not yet reported, Not yet reported Novartis Pharmaceuticals 393 participants Est. completion 2022-01-03 98 sites Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT02768298

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

Not yet reported Novartis Pharmaceuticals 201 participants Est. completion 2019-11-25 34 sites Stand-alone

Heart failure
View official trial listing →
Status unknown NCT NCT02817503

Feasibility Study of the Intensive Systolic Blood Pressure Control

Not yet reported Second Affiliated Hospital of Nanchang University 100 participants Est. completion 2016-12 1 site Stand-alone

Other conditions: Hypertension, Hyperhomocysteinemia
View official trial listing →
Completed NCT NCT02874794

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

Not yet reported Novartis Pharmaceuticals 465 participants Est. completion 2019-01-26 81 sites Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT02879721

Expression and Function of the Renin-Angiotensin System in the Esophagus

Not yet reported Göteborg University 33 participants Est. completion 2012-12 1 site

Other conditions: Barrett's Esophagus
View official trial listing →
Completed NCT NCT02900378

randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure

Not yet reported Novartis Pharmaceuticals 621 participants Est. completion 2018-04-11 119 sites Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT02970669

Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients.

Not yet reported Novartis Pharmaceuticals 140 participants Est. completion 2018-03-19 23 sites Stand-alone

Heart failure
View official trial listing →
Withdrawn NCT NCT03005184

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Not yet reported Vanderbilt University Medical Center Est. completion 2020-01 1 site Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT03051282

Genetic Determinants of ACEI Prodrug Activation

Not yet reported University of Michigan 21 participants Est. completion 2026-01-01 1 site

Other conditions: Healthy Volunteers
View official trial listing →
Completed NCT NCT03066804

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

Not yet reported Novartis Pharmaceuticals 2572 participants Est. completion 2019-10-28 380 sites Stand-alone

Heart failure
View official trial listing →
Suspended NCT NCT03071653

Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study

Not yet reported University of Cape Town 30 participants Est. completion 2022-02 1 site

Other conditions: Dilated Cardiomyopathy, Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy
View official trial listing →
Withdrawn NCT NCT03119623

Comparing ARNI With ACE Inhibitor on Endothelial Function

Not yet reported Brigham and Women's Hospital Est. completion 2019-08

Heart failure
View official trial listing →
Terminated NCT NCT03179163

Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans

Not yet reported, Not yet reported Penn State University 10 participants Est. completion 2022-12-31 1 site Stand-alone

Other conditions: Hypertension,Essential
View official trial listing →
Completed NCT NCT03190304

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

Not yet reported University of Sao Paulo General Hospital 52 participants Est. completion 2020-09-23 1 site Stand-alone

Heart failure Other conditions: Exercise Tolerance, Vasodilation, Body Composition, Muscle Strength
View official trial listing →
Status unknown NCT NCT03259399

A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients.

Cui Yimin 2200 participants Est. completion 2020-06 1 site

Cardiovascular disease Other conditions: Enalapril Adverse Reaction, Pharmacogenomics
View official trial listing →
Completed NCT NCT03265574

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Not yet reported South Tees Hospitals NHS Foundation Trust 111 participants Est. completion 2023-08-04 1 site Stand-alone

Other conditions: Breast Cancer, Non Hodgkin Lymphoma
View official trial listing →
Completed NCT NCT03466333

Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia

Not yet reported Manchester University NHS Foundation Trust 118 participants Est. completion 2020-09-11 1 site Stand-alone

Cardiovascular disease Other conditions: Pre-Eclampsia Onset Less Than 37 Weeks (Diagnosis)
View official trial listing →
Status unknown NCT NCT03472508

H-Type Hypertension Precision Medicine Trial

Not yet reported Shenzhen Ausa Pharmed Co.,Ltd 3600 participants Est. completion 2019-06-30 5 sites

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT03502031

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

Not yet reported James A. Tumlin, MD 72 participants Est. completion 2024-10-01 2 sites

Chronic kidney disease Other conditions: Renal Insufficiency, Chronic
View official trial listing →
Status unknown NCT NCT03526042

Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis

Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40 participants Est. completion 2019-10-31 1 site

Other conditions: Atherosclerosis, Lupus Nephritis
View official trial listing →
Completed NCT NCT03667131

Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

Not yet reported University of Guadalajara 59 participants Est. completion 2018-02-19 1 site Stand-alone

Other conditions: Rheumatoid Arthritis
View official trial listing →
Completed NCT NCT03917459

COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure

Not yet reported Novartis Pharmaceuticals 27 participants Est. completion 2021-05-25 13 sites

Heart failure Other conditions: Erectile Dysfunction
View official trial listing →
Completed NCT NCT03949075

Impact of Angiotensin Converting Enzyme Activity on Exercise Training Sensitivity

Not yet reported University of Copenhagen 52 participants Est. completion 2019-12-30 1 site Stand-alone

Other conditions: Exercise, Angiotensin-Converting Enzyme Inhibitors
View official trial listing →
Completed NCT NCT04023227

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Not yet reported Novartis Pharmaceuticals 922 participants Est. completion 2025-03-31 79 sites

Heart failure Other conditions: Chagas Disease
View official trial listing →
Completed NCT NCT04236258

Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period

Not yet reported Brigham and Women's Hospital 94 participants Est. completion 2021-06-30 1 site

Other conditions: Hypertension in Pregnancy, Preeclampsia Severe, Gestational Hypertension, Postpartum Preeclampsia, Postpartum
View official trial listing →
Suspended NCT NCT04330300

Coronavirus (COVID-19) ACEi/ARB Investigation

Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site

Other conditions: Hypertension, COVID-19
View official trial listing →
Not yet recruiting NCT NCT04345406

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

Not yet reported Tanta University 60 participants Est. completion 2029-12-01 1 site Stand-alone

Other conditions: COVID
View official trial listing →
Completed NCT NCT04467931

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

University of Utah 22213 participants Est. completion 2020-12-31 1 site

Other conditions: Hypertension, COVID
View official trial listing →
Completed NCT NCT04484350

Blood Pressure Management in Stroke Following Endovascular Treatment

Not yet reported Hamilton Health Sciences Corporation 30 participants Est. completion 2023-05-04 1 site Stand-alone

Cardiovascular disease Other conditions: Vessels; Occlusion, Blood Pressure, Endovascular Thrombectomy, Mechanical Thrombectomy
View official trial listing →
Completed NCT NCT04591210

The COVID-RASi Trial (COVID-19)

Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sites Stand-alone

Cardiovascular disease Other conditions: COVID-19
View official trial listing →
Completed NCT NCT04640571

Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition

Not yet reported University of Maryland, Baltimore 18 participants Est. completion 2021-11-01 1 site

Other conditions: Bile Salt Export Pump (BSEP) Transporter, Polysorbate 80
View official trial listing →
Completed NCT NCT04736329

Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions

Not yet reported Cairo University 107 participants Est. completion 2022-10-31 1 site

Heart failure Other conditions: Renal Insufficiency
View official trial listing →
Status unknown NCT NCT04853758

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

Not yet reported University of Sao Paulo General Hospital 200 participants Est. completion 2024-12-01 1 site

Other conditions: Chagas Cardiomyopathy
View official trial listing →
Status unknown NCT NCT04912167

The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction

Not yet reported West China Hospital 376 participants Est. completion 2026-06 1 site

Other conditions: STEMI
View official trial listing →
Completed NCT NCT04937907

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)

Not yet reported Shanghai Children's Hospital 50 participants Est. completion 2024-12-31 1 site Stand-alone

Other conditions: Alport Syndrome, X-Linked
View official trial listing →
Completed NCT NCT04952051

Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H Hypertension

Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 1000 participants Est. completion 2020-07-01 1 site Stand-alone

Other conditions: Hypertension
View official trial listing →
Completed NCT NCT05232370

The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

Not yet reported Unidad de Investigacion Medica en Enfermedades Renales 39 participants Est. completion 2022-01-06 1 site Stand-alone

Other conditions: Oxidative Stress
View official trial listing →
Withdrawn NCT NCT05259137

Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars

Not yet reported, Not yet reported Nova Scotia Health Authority Est. completion 2026-10

Other conditions: Hypertrophic Scar
View official trial listing →
Status unknown NCT NCT05271448

Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

Not yet reported An-Najah National University 600 participants Est. completion 2024-08-01 1 site Stand-alone

Chronic kidney disease Other conditions: Contrast-induced Nephropathy, Ischemic Heart Disease
View official trial listing →
Status unknown NCT NCT05373004

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

Not yet reported, Not yet reported Omar Tarek Elfarargi 212 participants Est. completion 2024-05 Stand-alone

Chronic kidney disease
View official trial listing →
Completed NCT NCT05402397

Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

Not yet reported Hospital General de Niños Pedro de Elizalde 40 participants Est. completion 2024-01-01 1 site Stand-alone

Other conditions: Uric Acid Nephropathy
View official trial listing →
Completed NCT NCT05479097

Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage

Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2023-12-31 1 site

Other conditions: Hypertension
View official trial listing →
Status unknown NCT NCT05487261

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction

Not yet reported Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań 260 participants Est. completion 2025-11 5 sites Stand-alone

Heart failure
View official trial listing →
Active, not recruiting NCT NCT05637853

Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 site Stand-alone

Heart failure
View official trial listing →
Completed NCT NCT05711810

Medicine-induced Cardiac Hemodialysis on COVID-19

Not yet reported Yang I. Pachankis 1 participants Est. completion 2023-01-12 1 site Stand-alone

Other conditions: Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines, Myocarditis Allergic, Infection Viral
View official trial listing →
Status unknown NCT NCT06187493

Treatment of Patients With Diabetic Kidney Disease

Not yet reported Assiut University 70 participants Est. completion 2025-12-31

Chronic kidney disease
View official trial listing →
Status unknown NCT NCT06515678

Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites

Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
View official trial listing →
Completed NCT NCT06545461

Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

Not yet reported Donald Wesson 108 participants Est. completion 2016-10-30 Stand-alone

Chronic kidney diseaseCardiovascular disease Other conditions: Hypertension
View official trial listing →
Completed NCT NCT06697353

An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

Bayer 4936 participants Est. completion 2025-09-19 1 site

Heart failure
View official trial listing →
Completed NCT NCT06710600

Phototoxicity of Frequently Prescribed Medicines

Not yet reported Medical University of Vienna 12 participants Est. completion 2024-10-03 1 site

Other conditions: Phototoxicity
View official trial listing →
Not yet recruiting NCT NCT07262710

Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19

Cardiovascular disease
View official trial listing →
Completed NCT NCT07436104

Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.

Not yet reported MAHAN Trust 72564 participants Est. completion 2023-08-31 1 site Stand-alone

Other conditions: Hypertension (HTN), Diarrhea, Pneumonia, Malaria Fever, COPD, Asthma (Diagnosis), Diarrhea Chronic
View official trial listing →
Enrolling by invitation NCT NCT07547878

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site

Chronic kidney diseaseType 2 diabetes
View official trial listing →
Enrolling by invitation NCT NCT07568574

Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes

Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-alone

Other conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT07547878

Also known as: Enalapril Maleate, Enalapril

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.